Cargando…
MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
Doxorubicin (DOX) is a chemotherapeutic drug widely used for cancer treatment, but its use is limited by cardiotoxicity. Although free radicals from redox cycling and free cellular iron have been predominant as the suggested primary pathogenic mechanism, novel evidence has pointed to topoisomerase I...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720152/ https://www.ncbi.nlm.nih.gov/pubmed/36479202 http://dx.doi.org/10.3389/fphar.2022.1055911 |